However, we found that the expression of NSDHL in mouse cholangiocytes promoted the AKT- and YAPS127A-induced development of cholangiocarcinoma (Fig. 2E), and elevated the number of Ki67-positive cells. Here, NSDHL is linked to cholangiocarcinoma.